Curiosis
큐리오시스 · 494120
Information Technology Components · KOSDAQ
Market cap US$165.6M (₩228.5B)
Overview
Curiosis makes laboratory automation equipment, instruments that let scientists observe living cells growing inside incubators and separate specific cells or blood components without manual handling.
Its products are used in life-science research, drug development, diagnostics, and the production of cell-based therapies. Listed on KOSDAQ, Korea's tech-focused small-cap board, the company designs and manufactures its products in-house, with its live-cell imaging system, the Celloger® series, serving as its primary revenue-driving product line.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2025US$5.3M
Operating profit
- FY2025−US$5.5M
Net income
- FY2025−US$5.7M
Key ratios (FY2025)
Why it matters
Curiosis has received recognition from Korea's Ministry of Trade, Industry and Energy, which designated the Celloger® as a 'World Class Product', a formal Korean government certification for globally competitive exports.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?